Gossamer Bio Statistics

Total Valuation

Gossamer Bio has a market cap or net worth of $265.85 million. The enterprise value is $174.21 million.

Market Cap	265.85M
Enterprise Value	174.21M

Important Dates

The last earnings date was Thursday, March 13, 2025, after market close.

Earnings Date	Mar 13, 2025
Ex-Dividend Date	n/a

Share Statistics

Gossamer Bio has 227.22 million shares outstanding. The number of shares has increased by 48.23% in one year.

Current Share Class	227.22M
Shares Outstanding	227.22M
Shares Change (YoY)	+48.23%
Shares Change (QoQ)	+0.11%
Owned by Insiders (%)	3.13%
Owned by Institutions (%)	61.68%
Float	183.67M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	2.31
Forward PS	12.32
PB Ratio	8.99
P/TBV Ratio	9.01
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	1.52
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 6.88, with a Debt / Equity ratio of 6.88.

Current Ratio	6.88
Quick Ratio	6.66
Debt / Equity	6.88
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-5.20

Financial Efficiency

Return on equity (ROE) is -122.54% and return on invested capital (ROIC) is -14.76%.

Return on Equity (ROE)	-122.54%
Return on Assets (ROA)	-11.94%
Return on Invested Capital (ROIC)	-14.76%
Return on Capital Employed (ROCE)	-22.17%
Revenue Per Employee	$791,041
Profits Per Employee	-$389,848
Employee Count	145
Asset Turnover	0.37
Inventory Turnover	n/a

Taxes

In the past 12 months, Gossamer Bio has paid $893,000 in taxes.

Income Tax	893,000
Effective Tax Rate	n/a

Stock Price Statistics

Beta (5Y)	1.86
52-Week Price Change	n/a
50-Day Moving Average	1.19
200-Day Moving Average	0.97
Relative Strength Index (RSI)	44.03
Average Volume (20 Days)	1,490,087

Short Selling Information

The latest short interest is 5.74 million, so 2.53% of the outstanding shares have been sold short.

Short Interest	5.74M
Short Previous Month	5.59M
Short % of Shares Out	2.53%
Short % of Float	3.13%
Short Ratio (days to cover)	3.32

Income Statement

In the last 12 months, Gossamer Bio had revenue of $114.70 million and -$56.53 million in losses. Loss per share was -$0.25.

Revenue	114.70M
Gross Profit	114.70M
Operating Income	-59.92M
Pretax Income	-172.58M
Net Income	-56.53M
EBITDA	-59.09M
EBIT	-59.92M
Loss Per Share	-$0.25

Full Income Statement

Balance Sheet

The company has $294.52 million in cash and $202.88 million in debt, giving a net cash position of $91.64 million or $0.40 per share.

Cash & Cash Equivalents	294.52M
Total Debt	202.88M
Net Cash	91.64M
Net Cash Per Share	$0.40
Equity (Book Value)	29.49M
Book Value Per Share	0.13
Working Capital	264.88M

Full Balance Sheet

Cash Flow

Operating Cash Flow	-3.47M
Capital Expenditures	n/a
Free Cash Flow	-3.47M
FCF Per Share	-$0.02

Full Cash Flow Statement

Margins

Gross margin is 100.00%, with operating and profit margins of -52.24% and -49.28%.

Gross Margin	100.00%
Operating Margin	-52.24%
Pretax Margin	-48.50%
Profit Margin	-49.28%
EBITDA Margin	-51.51%
EBIT Margin	-52.24%
FCF Margin	n/a

Dividends & Yields

Gossamer Bio does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-48.23%
Shareholder Yield	n/a
Earnings Yield	-21.26%
FCF Yield	-1.30%

Analyst Forecast

The average price target for Gossamer Bio is $9.20, which is 686.33% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$9.20
Price Target Difference	686.33%
Analyst Consensus	Strong Buy
Analyst Count	5
Revenue Growth Forecast (5Y)	25.73%
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Gossamer Bio has an Altman Z-Score of -4.45 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-4.45
Piotroski F-Score	2